Dear colleagues and students
It is with great sadness that we write to inform you of the death of Dr Alissa Myrick (43), an infectious disease molecular biologist and chief investigator at the UCT Drug Discovery and Development Centre, H3D. She passed away on the morning of Thursday, 7 November 2019, following complications resulting from an operation she underwent in July 2019.
Dr Myrick joined H3D from Harvard University in the United States in January 2016 and used her wealth of biological expertise to establish and grow tuberculosis (TB) biology drug discovery efforts at H3D. She had over a decade of experience studying the molecular mechanisms of drug resistance in both malaria and TB, with a particular interest in the basic biology of efflux pumps and defining their role in modulating resistance.
Alissa will be remembered as a daughter, a sister, a mom, a friend, a colleague, a scholar, a scientist, an educator, a mentor and an activist. She was quick to smile and had a fierce commitment to her work, her friends and, above all, her daughter. She was a rock star and a change-maker with so much left to give.
A memorial service will be held on Tuesday, 19 November 2019 at 10:30 in the Smuts Hall Upper Common Room on Upper Campus.
Dr Myrick is survived by her daughter Sophia Castillian, her mother Barryett Enge, and brothers Fredrick and Christopher Myrick. We convey our heartfelt condolences to Dr Myrick’s family, friends and all who knew her.
The UCT Executive
Read previous communications:
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Please view the republishing articles page for more information.